Menu Search
Equities

Cambridge Cognition Holdings PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1M7:STU

Cambridge Cognition Holdings PLC

Actions
  • Price (EUR)0.422
  • Today's Change0.006 / 1.44%
  • Shares traded0.00
  • 1 Year change-19.62%
  • Beta1.2305
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Cambridge Cognition Holdings plc is a United Kingdom-based brain health software company, which is engaged in developing and marketing digital solutions to assess brain health, principally in the United Kingdom, the United States and Europe. Its products include CANTAB, Electronic Clinical Outcomes Assessment (eCOA), NeuroVocalix, Winterlight, Cognition Kit, Clinpal, eConsent, and AQUA. CANTAB Connect gives the control to manage and deliver a battery of touchscreen and voice assessments, as well as fully customizable electronic questionnaires and scales. Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone apps for high frequency data collection. The Company’s therapeutic areas include attention deficit hyperactivity disorder (ADHD), Alzheimer’s Disease, Autism Spectrum Disorder, Depression, Down’s Syndrome, Drug Abuse Liability, Epilepsy, Parkinson’s Disease, Stroke and Cerebrovascular Disease, and Traumatic Brain Injury, among others.

  • Revenue in GBP (TTM)9.05m
  • Net income in GBP-1.67m
  • Incorporated2012
  • Employees84.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.